BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2287 related articles for article (PubMed ID: 32100877)

  • 1. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
    Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
    J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of receptor recognition by SARS-CoV-2.
    Shang J; Ye G; Shi K; Wan Y; Luo C; Aihara H; Geng Q; Auerbach A; Li F
    Nature; 2020 May; 581(7807):221-224. PubMed ID: 32225175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
    Behloul N; Baha S; Shi R; Meng J
    Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
    Wan Y; Shang J; Graham R; Baric RS; Li F
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31996437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans.
    Frutos R; Serra-Cobo J; Chen T; Devaux CA
    Infect Genet Evol; 2020 Oct; 84():104493. PubMed ID: 32768565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction.
    Witkowska D
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32927621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
    Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I
    Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
    Wrobel AG; Benton DJ; Xu P; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nat Struct Mol Biol; 2020 Aug; 27(8):763-767. PubMed ID: 32647346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
    Tan HW; Xu YM; Lau ATY
    Rev Med Virol; 2020 Sep; 30(5):e2122. PubMed ID: 32602627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2).
    Masood N; Malik SS; Raja MN; Mubarik S; Yu C
    Front Cell Infect Microbiol; 2020; 10():499. PubMed ID: 32974224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
    Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach.
    Lokman SM; Rasheduzzaman M; Salauddin A; Barua R; Tanzina AY; Rumi MH; Hossain MI; Siddiki AMAMZ; Mannan A; Hasan MM
    Infect Genet Evol; 2020 Oct; 84():104389. PubMed ID: 32502733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facing the COVID-19 outbreak: What should we know and what could we do?
    Yang Y; Shang W; Rao X
    J Med Virol; 2020 Jun; 92(6):536-537. PubMed ID: 32091134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 115.